European equities traded in the US as American depositary receipts were sharply higher late Wednesday morning, climbing 1.85% to 1,377.63 on the S&P Europe Select ADR Index. From continental Europe, ...

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the ...

The company recently secured approval for olezarsen in FCS, and looks odds on for a follow-up approval in SHTG. Click here to ...

BioNTech SE (BNTX) reports a net profit for Q4 2024 amidst a challenging year, with strategic advancements in oncology and ...

Shares of Finance sector company Webull moved -6.2% today, and are now trading at a price of $24.69. The Large-Cap stock's ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $140.00.

Biotechnology company BioNTech SE is taking Wall Street by surprise today, falling to $97.73 and marking a -4.5% change ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...

BioNTech (BNTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Zai Lab Limited (ZLAB) saw its shares surge in the last session with trading volume being higher than average. The latest ...

Morgan Stanley analyst Terence Flynn maintained a Buy rating on BioNTech SE (BNTX – Research Report) today and set a price target of $140.00.